The metabolic effects of ovine placental lactogen (oPL) alone and in combination with bovine GH (bGH) 
Introduction
Growth hormone (GH) is a well-known anabolic and anticatabolic agent. GH deficiency in adulthood is associ¬ ated with a decrease in lean body mass and a reduction of muscle mass which can be restored by GH replacement therapy (Jorgensen et al. 1989 , Salomon et al. 1989 ). GH treatment results in an improved nitrogen balance in catabolic subjects, such as patients recovering from surgery (Douglas et al. 1990 ), calorically restricted obese subjects (Clemmons et al. 1987) or volunteers with glucocorticoidinduced catabolism (Horber & Haymond 1990) . We have previously shown in sheep that long-term recombinant bovine GH (bGH) treatment increased body protein content (Sauerwein et al. 1991) , and that short-term bGH treatment reduced the rate of net protein catabolism (Koea et al. 1993 ).
Ovine placental lactogen (oPL) is a 22 kDa polypeptide hormone which is produced by the chorionic binucleate cells of the sheep placenta and released into both the fetal and maternal circulation (Kappes et al. 1992) . Although oPL has a relatively low sequential homology with ovine GH (oGH; 28%) (Colosi et al. 1989) , there is increasing evidence that it binds to the oGH receptor (oGHR) with higher affinity than oGH (Breier et al. 19946 ). The biological functions of this placental hormone still remain uncertain. Since oPL is a member of the GH/prolactin (PRL) family, it has been suggested that it has GH-like diabetogenic, lipolytic, anabolic and anticatabolic actions as well as PïCL-like lactogenic action (Handwerger 1991 , Byatt et al. 1992 . It has been shown that recombinant oPL has a marked somatogenic action in terms of promoting growth and stimulating plasma insulin-like growth factor (IGF)-I in the dwarf rat (Singh et al. 1992) , suggesting that it may bind to and function through the GHR in this species. It has also been shown that, in vitro, purified oPL has stimulatory effects on ornithine decarboxylase activity in fetal rat hver (Hurley et al. 1980) , and enhances amino acid transport in fetal (Freemark & Handwerger 1983 ) and postnatal (Freemark & Handwerger 1982) (Fuh et al. 1992) . oPL has been shown to bind to oGHR more potently than oGH (Breier et al. 1994b ) and may bind to oGHR in a monomeric fashion in the same way that bPL binds to the bGHbinding protein (bGHBP) at a 1:1 stoichiometry (Staten et al. 1993) .
The objective of this study was to compare the biologi¬ cal effects of oPL and bGH particularly on plasma IGF-I levels and protein metabolism in the postnatal lamb, and also to investigate whether oPL can antagonize the known effects of bGH when given in combination.
Materials and Methods

Study design
The experimental protocol is shown in Fig. 1 . The lambs used in this study were cross-bred castrated males with average weights of 18-9 kg and average ages of 78 days at the end of the study. (Kerscher & Ziegenhorn 1985) . Both of them were modified for assay using a 96-well microplate reader (Ashour et al. 1987 ). Mean intra-and interassay coef¬ ficients of variation for FFA and urea were 1-4% and 5-3%, 3-8% and 3-9% respectively.
Hormone assays
Plasma levels of IGF-I were determined with a double antibody RIA using a rabbit antiserum to rh-Met IGF-I (878/4) at a final titre of 1:250 000 following extraction of plasma-binding proteins using the acid-ethanol cryoprecipitation technique . Excess IGF-II was added in order to remove the interfering effect of IGFbinding proteins. This assay has been extensively validated for sheep plasma (Breier et al. 1994d ). Plasma levels of insuhn (Gallaher et al. 1992) , oPL (Ohver et al. 1992 ) and oGH (Gluckman et al. 1919b) were measured by RIA as previously described. Mean intra-and interassay coef¬ ficients of variation were respectively: IGF-I, 4-5% and 7-2%; insulin, 6-7% and 11-5%; oPL, 5-1% and 9-7%; oGH, 6-0% and 10-0%.
Net protein catabolism Plasma urea specific activity was determined using the Steele equation as it applies to isotopie steady state (Wolfe 1984) . From the specific activity data, the value of the rate of net protein catabolism (NPC) was derived as described elsewhere (Shaw et al. 1987 (Fig. 3a) . A significant negative correlation was observed between NPC and plasma IGF-I levels during treatment over all groups (r=-0-62, <0 01) (Fig. 3b) . (Hurley et al. 1980) , and enhanced amino acid transport in fetal (Freemark & Handwerger 1983 ) and postnatal (Freemark & Handwerger 1982) have an independent effect on circulating IGF-I levels in the postnatal lamb. This is consistent with a recent study in the pregnant ewe (Min et al. 1994) .
It has been suggested that oPL may affect carbohydrate metabolism (Handwerger 1991 (Breier et al. 1994è) , although the presence of a distinct oPL receptor has been proposed (Freemark et al. 1987 , Fiddes et al. 1992 . These results strongly suggest that oPL binds to the oGH receptor. It is, therefore, not surprising that, in the present study, a highly significant correlation between 125I-labelled oPL and 125I-labelled oGH binding to the hepatic microsomal membranes was observed. Never¬ theless, oPL treatment alone failed to affect any of the metabolic or endocrine parameters in the present study.
It should be noted that this study was performed in non-pregnant animals. It is possible that the endocnne milieu of pregnancy alters the responses of tissues to oPL.
However, the previous study of oPL in pregnant sheep reached similar conclusions in which oPL is neither somatogenic nor diabetogenic (Min et al. 1994) . In ad¬ dition, the plasma concentrations of oPL in our study (90-100 ng/ml) were comparable with peak levels in pregnant ewes (125 ng/ml, authors' unpubhshed obser¬ vation) which are observed around 120-130 days of gestation (Gluckman et al. 1919a Similarly, the combined treatment caused relative insuhn resistance while neither bGH nor oPL alone did. In addition, the increase in plasma IGF-I levels was signifi¬ cantly greater in the bGH+oPL group than in the bGH alone group, although the effect was small. These results suggest that oPL may potentiate the effects of bGH rather than acting as an antagonist. The combined treatment of hGH and hPL was previously reported in the hypophy¬ sectomized rat to be more somatogenic and diabetogenic than hGH alone, whereas hPL alone had no effect (Josimovich 1966 (Koea et al. 1992) . These data support the hypothesis that circulating IGF-I has a role in the regu¬ lation of whole body protein metabohsm (Gluckman et interactions between oPL and the plasma GHBPs, to which oPL binds with high affinity, may be involved. A physiological role for oPL during pregnancy might be the induction of insulin resistance and the increase of maternal IGF-I, both of which lead to fetal growth as proposed previously (Grumbach et al. 1968 , Handwerger 1991 . These effects may be indirect and mediated by augmen¬ tation of the effects of GH.
